CIK 0000014272
- Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 220790350
- Phone
- +1 609-252-4621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-30 | Dubow Adam SVP,ChiefCompliance&EthicsOff. | Sale | −2,466 | $67.90 | $167K | 13,777.15 |
| 2021-07-30 | LEUNG SANDRA EVP, General Counsel | Sale | −29,390 | $68.04 | $2.0M | 339,967.33 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Sale | −17,740 | $68.01 | $1.2M | 36,650 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +5,843 | $58.78 | $343K | 42,493 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +6,305 | $63.41 | $400K | 48,798 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +1,651 | $60.53 | $100K | 50,449 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +1,454 | $54.20 | $79K | 51,903 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +373 | $56.44 | $21K | 52,276 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +29,489 | $63.41 | $1.9M | 81,765 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +5,843 | $61.01 | $356K | 87,608 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +2,905 | $54.20 | $157K | 90,513 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +17,630 | $56.44 | $995K | 108,143 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +24,134 | $61.34 | $1.5M | 132,277 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +22,483 | $60.53 | $1.4M | 154,760 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +15,879 | $55.52 | $882K | 170,639 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +8,489 | $44.70 | $379K | 179,128 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +8,489 | $47.81 | $406K | 187,617 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Sale | −140,653 | $68.08 | $9.6M | 46,964 |
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise · Option (right to buy) | −5,843 | 0 | ||
| 2021-07-30 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise · Option (right to buy) | −6,305 | 0 |
Page 69 of 73 · 1,445 trades